Under-recognised paradox of neuropathy from rapid glycaemic control.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15701742.
- Also identified by PMC identifier 1743196.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Insulin induced neuropathy has been reported previously in people with diabetes treated with insulin, and subsequently reported in patients with insulinomas. However, neuropathy caused by rapid glycaemic control in patients with poorly controlled diabetes with chronic hyperglycaemia is not a widely recognised entity among clinicians worldwide. It is expected that this phenomenon of paradoxical complication of neuropathy in the face of drastic decreases in glycosylated haemoglobin concentrations will assume greater importance with clinicians achieving glycaemic targets at a faster pace than before.
Medical subject headings
- Diabetic Neuropathies
- Glycated Hemoglobin
- Hyperglycemia
- Hypoglycemia
- Hypoglycemic Agents
- Insulin